We are live on ! Find out more
CRBU icon

Caribou Biosciences
CRBU

Fund managers haven’t disclosed any holdings of CRBU yet.

CRBU Hedge Fund Activity: Q1 2026 in Review

137 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q1 2026, worth a combined $71.3M — up 20% from $59.6M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new CRBU positions and 13 closed out — a net gain of 15 holders — while 27 added to existing stakes and 39 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.63M. The largest seller was Jacobs Levy Equity Management, cutting an estimated $799K.

  • 137 institutional investors held Caribou Biosciences (CRBU) as of Q1 2026, up from 124 in Q4 2025.
  • Funds reported $71.3M of Caribou Biosciences stock for Q1 2026, up 20% quarter-over-quarter.
  • 28 funds opened new Caribou Biosciences positions in Q1 2026 and 13 closed out, a net change of +15 holders.
  • The largest Caribou Biosciences buyer in Q1 2026 was Renaissance Technologies, an estimated $1.63M added.
  • The largest Caribou Biosciences seller in Q1 2026 was Jacobs Levy Equity Management, an estimated $799K sold.

Based on aggregated 13F filings for Q1 2026.